Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kari L Ring

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|October 30, 2024
High-grade Endometrial Carcinomas With Solid Basaloid Morphology and Geographic Necrosis Lacking Definitive Pilomatrix-like Features: Clinicopathologic Characteristics Including Aggressive Behavior and Novel Molecular EventsDavid K Carlson, Cheyenne Painter, Sarah E Gradecki, et al.
Human Pathology|July 1, 2018
Clinicopathologic characterization of breast carcinomas in patients with non-BRCA germline mutations: results from a single institution's high-risk populationAlice E Meiss, Martha Thomas, Susan C Modesitt, et al.
Gynecologic Oncology Reports|June 4, 2020
Evaluation of breast screening strategies in a high risk breast and ovarian cancer clinicAnne T Knisely, Martha E Stewart, Christine Garcia, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 15, 2016
Clinical Challenges Associated with Universal Screening for Lynch Syndrome-Associated Endometrial CancerAmanda S Bruegl, Kari L Ring, Molly Daniels, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 12, 2024
What Is the Cost: Financial Toxicity and Screening Fatigue in Li-Fraumeni SyndromeKaylee A Underkofler, Martha H Thomas, Sarah H Erickson, et al.
Hereditary Cancer in Clinical Practice|August 11, 2023
Factors affecting adherence to a high-risk surveillance protocol among patients with Li-Fraumeni syndromeKaylee A Underkofler, Martha H Thomas, Christina J Taylor, et al.
Journal of Genetic Counseling|February 2, 2019
Cases and evidence for panel testing in cancer genetics: Is site-specific testing dead?Martha H Thomas, Lydia K Higgs, Susan C Modesitt, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 13, 2015
Make New Friends But Keep the Old: Minimally Invasive Surgery Training in Gynecologic Oncology Fellowship ProgramsKari L Ring, Pedro T Ramirez, Lesley B Conrad, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 11, 2015
Role of Minimally Invasive Surgery in Gynecologic Oncology: An Updated Survey of Members of the Society of Gynecologic OncologyLesley B Conrad, Pedro T Ramirez, William Burke, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 12, 2021
MLH1/PMS2-deficient Endometrial Carcinomas in a Universally Screened Population: MLH1 Hypermethylation and Germline Mutation StatusBrett Kurpiel, Martha S Thomas, Mansoor Mubeen, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|October 30, 2024
High-grade Endometrial Carcinomas With Solid Basaloid Morphology and Geographic Necrosis Lacking Definitive Pilomatrix-like Features: Clinicopathologic Characteristics Including Aggressive Behavior and Novel Molecular EventsDavid K Carlson, Cheyenne Painter, Sarah E Gradecki, et al.
Human Pathology|July 1, 2018
Clinicopathologic characterization of breast carcinomas in patients with non-BRCA germline mutations: results from a single institution's high-risk populationAlice E Meiss, Martha Thomas, Susan C Modesitt, et al.
Gynecologic Oncology Reports|June 4, 2020
Evaluation of breast screening strategies in a high risk breast and ovarian cancer clinicAnne T Knisely, Martha E Stewart, Christine Garcia, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 15, 2016
Clinical Challenges Associated with Universal Screening for Lynch Syndrome-Associated Endometrial CancerAmanda S Bruegl, Kari L Ring, Molly Daniels, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 12, 2024
What Is the Cost: Financial Toxicity and Screening Fatigue in Li-Fraumeni SyndromeKaylee A Underkofler, Martha H Thomas, Sarah H Erickson, et al.
Hereditary Cancer in Clinical Practice|August 11, 2023
Factors affecting adherence to a high-risk surveillance protocol among patients with Li-Fraumeni syndromeKaylee A Underkofler, Martha H Thomas, Christina J Taylor, et al.
Journal of Genetic Counseling|February 2, 2019
Cases and evidence for panel testing in cancer genetics: Is site-specific testing dead?Martha H Thomas, Lydia K Higgs, Susan C Modesitt, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 13, 2015
Make New Friends But Keep the Old: Minimally Invasive Surgery Training in Gynecologic Oncology Fellowship ProgramsKari L Ring, Pedro T Ramirez, Lesley B Conrad, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 11, 2015
Role of Minimally Invasive Surgery in Gynecologic Oncology: An Updated Survey of Members of the Society of Gynecologic OncologyLesley B Conrad, Pedro T Ramirez, William Burke, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 12, 2021
MLH1/PMS2-deficient Endometrial Carcinomas in a Universally Screened Population: MLH1 Hypermethylation and Germline Mutation StatusBrett Kurpiel, Martha S Thomas, Mansoor Mubeen, et al.
Pageof 6